First-line PD-1/PD-L1 inhibitors plus chemotherapy vs. chemotherapy alone in stage IIIB–IV non-squamous NSCLC: an updated meta-analysis of phase 3 RCTs
Authors
Yunwei Rao
Huanxin Liu (ORCID: https://orcid.org/0000-0002-6206-7724)
Y. Srinivasa Rao (ORCID: https://orcid.org/0000-0003-4876-3093)
First-line PD-1/PD-L1 inhibitors plus chemotherapy vs. chemotherapy alone in stage IIIB–IV non-squamous NSCLC: an updated meta-analysis of phase 3 RCTs
Yunwei Rao, Huanxin Liu, Y. Srinivasa Rao, Xinhai Wu et al.
Journal
BMC Cancer
Topics
Cancer Immunotherapy and Biomarkers
article
First-line PD-1/PD-L1 inhibitors plus chemotherapy vs. chemotherapy alone in stage IIIB–IV non-squamous NSCLC: an updated meta-analysis of phase 3 RCTs
Zhangqiu City People's Hospital (CN), Gannan Medical University (CN), First Affiliated Hospital of Gannan Medical University (CN), Weifang Chinese Medicine Hospital (CN)